Migraine medication showdown: which works better for patients?
NCT ID NCT06680206
First seen Jan 25, 2026 · Last updated May 24, 2026 · Updated 20 times
Summary
This study looked at how people with migraine feel about two types of acute medications: rimegepant and triptans. Researchers used data from a large national health survey in the US, focusing on over 1,300 adults who reported a migraine diagnosis. They compared treatment satisfaction, quality of life, work productivity, and healthcare use between the two groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pfizer
New York, New York, 10001, United States
Conditions
Explore the condition pages connected to this study.